Results 61 to 70 of about 2,355 (177)

Coinfección VIH leishmania HIV Leishmania coinfection

Iatreia, 1992
<p class="MsoNormal"><span style="font-size: 10pt; font-family: Arial">La disminución de las defensas del huésped consecutiva a la Infección por el VIH es la base de las complicaciones oportunistas del.
Iván Vélez
doaj  

Canine leishmaniosis in South America [PDF]

Parasites & Vectors, 2009
Canine leishmaniosis is widespread in South America, where a number of Leishmania species have been isolated or molecularly characterised from dogs. Most cases of canine leishmaniosis are caused by Leishmania infantum (syn. Leishmania chagasi) and Leishmania braziliensis. The only well-established vector of Leishmania parasites to dogs in South America
openaire   +2 more sources

Trends and Gaps in the Scientific Literature about the Effects of Nutritional Supplements on Canine Leishmaniosis

Pathogens
In canine leishmaniosis (CanL), complex interactions between the parasites and the immunological background of the host influence the clinical presentation and evolution of infection and disease.
Annalisa Previti, Vito Biondi, Diego Antonio Sicuso, Michela Pugliese, Annamaria Passantino   +4 more
doaj   +1 more source

Tongue, larynx and esophageal leishmaniosis in an immunocompetent patient: a case report with description of imaging findings and discussion of current literature: A case of multifocal mucosal leishmaniosis

Radiology Case Reports
Mucosal leishmaniosis (ML) is a rare manifestation of leishmaniosis, usually caused by Leishmania brasiliensis in northeast Brazil and by Leishmania infantum and Leishmania donovani in the Mediterranean Europe and Africa. We present the case of a 66-year-
Deniz Zan, Delphine Hoton, Sandra Schmitz, Valeria Onofrj   +3 more
doaj   +1 more source

Design and development of highly conserved, HLA-promiscuous T cell multiepitope vaccines against human visceral leishmaniasis

Frontiers in Immunology
IntroductionNo vaccine is currently licensed against human visceral leishmaniasis (VL), a fatal CD4+ T cell immunosupressive disease against which chemotherapy is reduced to a few toxic drugs.
Aline Silva Barreto, Aline Silva Barreto, Mariana Nobre Farias de Franca, Mariana Nobre Farias de Franca, Tatiana Leão dos Santos dos Reis, Tatiana Leão dos Santos dos Reis, Joao Antonio Barbosa Martins Silva, Priscila Lima Dos Santos, Priscila Lima Dos Santos, Fabrícia Alvisi de Oliveira, Angela Maria da Silva, Angela Maria da Silva, Lucas Sousa Magalhaes, Danielle Angst Secco, Maria Aiza Fontes Andrade, Luís Cristóvão Porto, Daniela Santoro Rosa, Rafael Ciro Marques Cavalcante, Cristiane Bani Corrêa, Cristiane Bani Corrêa, John Sidney, Alessandro Sette, Alessandro Sette, Roque Pacheco de Almeida, Clarisa Beatriz Palatnik-de-Sousa, Clarisa Beatriz Palatnik-de-Sousa   +25 more
doaj   +1 more source

Visceral Leishmaniosis and Canine Leishmaniosis in Greece and other mediterranean countries

Journal of the Hellenic Veterinary Medical Society, 2017
The prevalence of canine leishmaniosis in mediterranean countries varies from 0.2% to 67% and annually, 1.4-300 cases of human infection are reported in each country. In Greece, 0.7-48.7% of dogs, 3.9% of cats, 1.2% of rodents (Citellus citellus) and 3.9-9.2% of inhabitants are seropositive, whereas 25 cases (mean annual rate) of visceral leishmaniosis
S. CHARALABIDIS (Σ. Θ. ΧΑΡΑΛΑΜΠΙΔΗΣ), A. DIAKOU (Α. Ν. ΔΙΑΚΟΥ)   +1 more
openaire   +2 more sources

Critically Appraised Topic on Canine Leishmaniosis: Does Treatment with Antimonials and Allopurinol Have the Same Clinical and Clinicopathological Efficacy as Treatment with Miltefosine and Allopurinol, after One Month of Treatment?

Veterinary Sciences
The treatment of canine leishmaniosis commonly involves meglumine antimoniate with allopurinol or miltefosine with allopurinol. This study aims to compare the clinical and clinicopathological efficacy at 28–30 days of conventional dosing regimens for ...
Marina García, Lluís Ferrer, Laura Ordeix   +2 more
doaj   +1 more source

Diagnóstico de leishmaniosis visceral por frotis de sangre periférica. A propósito de un caso en Cojedes, Venezuela

Revista Peruana de Medicina Experimental y Salud Pública, 2009
En Venezuela se conoce la existencia de Leishmaniosis visceral desde 1941, y desde 1990 se notifican en promedio 50 casos por año, en focos separados ubicados en el centro, oeste sur y este del país.
Wladimir Ochoa, Luis Gutiérrez, Rafael Guevara, Milagros Oviedo, Lisbeth Loaiza, Gilberto Bastidas   +5 more
doaj  

Leishmaniosis cutanea: manifestación clínica inusual

Revista Peruana de Medicina Experimental y Salud Pública
Las manifestaciones clínicas de la leishmaniosis son variables y están relacionadas con la especie infectante, su relación con el medioambiente y con la respuesta inmune del hospedero.
Aidé Sandoval-Juárez, Gloria Minaya-Gómez, Nyshon Rojas-Palomino, Eduardo Falconi, Omar Cáceres   +4 more
doaj   +2 more sources

Chemotherapeutic Studies on Cutaneous Leishmaniosis

Experimental Biology and Medicine, 1961
SummaryThe cutaneous infection of mouse obtained with a strain of L. brasiliensis causing in man the leproid form represents a suitable test for chemotherapeutic investigation. The infection has not been influenced by the antibiotics Fungizone and Fumagillin recently reported to possess antileishmanial action against L. donovani(10).
openaire   +2 more sources